BioCentury
ARTICLE | Clinical News

BL-5010: Phase I/II started

June 29, 2009 7:00 AM UTC

BioLineRx began a single-arm, open-label, German and Dutch Phase I/II trial to evaluate BL-5010 in 60 patients. ...